If someone has intolerable side effects at a standard dose, I may adjust downward to maintain benefit without overwhelming the body, Dr
Even though semaglutide has been available for public use, numerous studies have been performed on this emerging treatment
The only time youll need to set aside is for the treatment sessions themselves
EFSA Journal, 23 (5), e9371
Semaglutide may be a strong option for patients who respond well to GLP-1 therapy, need a more established treatment path or tolerate it better
While Ozempic is only licensed in the UK for people with diabetes, the jabs have been prescribed off-label to people hoping to make use of its weight-loss properties while the rollout of Wegovy to treat obesity on the NHS has been delayed indefinitely